Diasys 3 Plus
Advanced Hybrid ABPM
Trusted by clinicians, embraced by patients — the Diasys 3 Plus is redefining ambulatory blood pressure monitoring
Diasys 3 Plus
Scientific Studies
Validation of the blood pressure measurement technology used in the Novacor Diasys 3 Plus…
Summary: The Novacor Diasys 3 Plus blood pressure monitor, when used with recommended cuffs, is accurate for ambulatory blood pressure measurement in adults. The auscultatory measurement technology met all requirements, with criterion 1 errors of +3.6 ± 2.7 mmHg for SBP and +3.0 ± 2.7 mmHg for DBP.
Long term worsening of arterial stiffness from monitoring of QKD interval predicts the occurrence of cardiovascular events...
Summary: A study of 555 hypertensive patients found that those with increased arterial stiffness had double the risk of cardiovascular events compared to those with stable or reduced arterial stiffness, independent of other factors.
How to measure arterial stiffness independently of blood pressure: the QKD method...
Summary: Ambulatory monitoring of QKD provides indices of arterial stiffness independent of blood pressure level and 24-hour blood pressure. This method has the potential to refine risk assessment in patients with low traditional risk scores.
Arterial stiffness (from monitoring of Qkd interval) predict the occurrence of cardiovascular events and total mortality
Summary: A study of 930 hypertensive patients over 12 years found arterial stiffness, measured by QKD interval, independently predicts cardiovascular events and all-cause deaths. This measurement is most predictive in low-risk patients.
Increased arterial stiffness is an independent predictor of atrial fibrillation in hypertensive patients
Summary: Arterial stiffness is a strong predictor of future atrial fibrillation in hypertensive patients, independently of age, 24-hour pulse pressure, and left atrial diameter. This finding was based on a cohort study of 853 patients with hypertension, with a mean follow-up of 102 months.
Determination of central blood pressure by a noninvasive method (brachial blood pressure and QKD interval): a noninvasive validation
Summary: A measure of central systolic blood pressure (cSBP) based on the QKD interval was validated against the SphygmoCor device. The QKD-based cSBP estimation algorithm, defined in a first cohort, showed good agreement with SphygmoCor in a second cohort and demonstrated comparable blood pressure variations during head-up tilt in a third cohort.
